Blood Screening Market Size

Blood Screening Market size was over USD 3 billion in 2024 and is poised to reach USD 6.54 billion by the end of 2037, growing at around 6.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of blood screening is assessed at USD 3.15 billion.

The growth of the market can be attributed to the increased prevalence of chronic diseases, such as heart problems, chronic kidney disease, and others. To diagnose underlying chronic illnesses in the human body and proceed with timely treatment, blood screening has a huge role to play. According to the World Health Organization, globally, around 18 million people succumb to death from cardiovascular problems. Moreover, according to the Centers for Disease Control and Prevention, in recent times, nearly 415 million people had diabetes worldwide, and by 2040, over half a billion of the world’s population is likely to develop diabetes.

In addition to these, complications occurring in pregnancies and related preventive screening often require blood screening procedures, further bolstering market growth. They are required to plan the best course of treatment in a variety of situations. According to the World Health Organization, every day, over 810 women die of pregnancy and childbirth-related problems. Furthermore, the surge in the count of COVID-19 patients and other infectious diseases is expected to propel the industry growth.